查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1818188

FeNO 測試市場報告：2031 年趨勢、預測與競爭分析

FeNO Testing Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球 FeNO 檢測市場前景光明，醫院和診所市場蘊藏著巨大機會。預計 2025 年至 2031 年期間，全球 FeNO 檢測市場的複合年成長率將達到 14.1%。該市場的主要促進因素包括呼吸系統疾病盛行率的上升、人們對早期診斷和個人化醫療的認知不斷提高，以及空氣污染水平的上升。

  • Lucintel 預測，由於氣喘和慢性呼吸系統疾病的盛行率不斷上升，依類型分類，一氧化氮獨立監測儀預計在預測期內將出現高速成長。
  • 根據應用，由於先進的醫療基礎設施和對呼吸護理計劃的高度認知，醫院預計將實現高成長。
  • 依地區分類，預計北美在預測期內將經歷最高的成長。

FeNO測試市場的新趨勢

由於技術進步、醫療保健政策以及對非侵入性診斷方法日益成長的需求，FeNO 檢測市場正在快速發展。這些新興趨勢反映了醫療保健領域的廣泛變化，包括對個人化醫療和更有效的慢性病管理的追求。以下是塑造 FeNO 檢測市場未來的五大關鍵趨勢。

  • 家用設備日益普及：可攜式、易於使用的 FeNO 檢測設備正在開發中，使患者能夠在家中監測自身病情。這一趨勢正在改變氣喘管理，為患者提供即時數據，並支持制定更個人化的治療方案。家用設備使患者能夠在就診之外隨時掌握病情，從而提高治療依從性並減少就診次數。隨著醫療保健模式轉向更加以患者為中心的模式，這些設備在幫助患者更有效地管理呼吸健康方面發揮關鍵作用。
  • 與數位健康平台整合：FeNO 檢測設備正日益與數位健康平台整合，從而實現數據無縫傳輸至醫療服務提供者。這一趨勢有助於更好地監測氣喘和其他呼吸系統疾病，即時數據則有助於醫生做出更明智的決策。 FeNO 檢測與電子健康記錄(EHR) 和遠端醫療平台的整合也透過增強患者與醫療專業人員之間的溝通，改善了患者照護，從而能夠及時調整治療方案並改善療效。
  • 設備小型化和便攜性的進步：市場持續見證著 FeNO 檢測設備的創新，使其變得更小、更便攜、更易於使用。小型化使醫療保健提供者能夠在更多環境中使用這些設備，例如行動診所和偏遠地區。這一趨勢使得 FeNO 檢測在醫療基礎設施有限的地區更容易獲得，因為在這些地區，攜帶式、小型設備更易於運輸和部署。攜帶式FeNO 檢測在農村地區和開發中國家尤其有益。
  • 非侵入性診斷工具需求日益成長：FeNO 檢測是醫療保健領域非侵入性診斷趨勢的一部分。隨著患者偏好微創方法，FeNO 檢測因其無需抽血或其他侵入性操作即可測量氣道發炎而日益普及。這一趨勢對於管理氣喘等需要頻繁監測的慢性疾病尤其重要。非侵入性檢測方法可提高患者的舒適度，並有望成為慢性病管理通訊協定的標準組成部分。
  • 擴大報銷範圍：隨著 FeNO 檢測的臨床益處日益得到認可，包括美國和歐洲國家在內的許多國家正在擴大 FeNO 檢測的報銷範圍。將 FeNO 檢測納入保險範圍可以降低成本門檻，使更多人群更容易獲得此檢測。在許多地區，FeNO 檢測已被納入氣喘管理的臨床指南，確保醫療保健提供者將 FeNO 檢測作為全面治療計劃的一部分。這一趨勢正在推動 FeNO 檢測的廣泛應用。

家用設備、數位整合、設備小型化、非侵入性診斷需求以及報銷政策的不斷擴大等新興趨勢正在顯著重塑FeNO檢測市場。這些趨勢將透過改善FeNO檢測的可及性並加強其與常規醫療保健實踐的整合來推動成長，最終改善全球呼吸系統疾病的管理。

FeNO 測試市場的最新趨勢

隨著技術的進步和廣泛應用，FeNO 檢測市場也出現了一系列近期趨勢。這些發展反映了產品設計的創新、人們對呼吸系統疾病的認知不斷提高以及醫療基礎設施的進步。以下是近期影響各地區 FeNO 檢測市場的一些關鍵趨勢：

  • 手持式 FeNO 測試儀的推出：FeNO 測試市場最重要的發展之一是手持式和可攜式FeNO 測試設備的推出。這些設備支援就地檢驗，使醫療保健提供者能夠更輕鬆地快速評估患者的氣道發炎。手持式測試儀擴大用於急診室、診所甚至家庭的氣喘監測。這一發展提高了 FeNO 測試的便利性和可近性，尤其是在資源有限的環境中。
  • 遠端醫療與 FeNO 檢測整合：隨著遠端醫療的興起，FeNO 檢測設備正被整合到遠端醫療平台。這種整合使患者能夠在家中進行 FeNO 測量，並與醫療保健提供者遠端共用數據。這一趨勢對慢性呼吸系統疾病患者尤其有利，因為它可以持續監測並及時調整治療方案。它還能改善專科醫療的可近性，尤其是在農村和服務不足的地區。
  • 提升設備靈敏度和準確度：近期進展主要集中在提高 FeNO 檢測設備的靈敏度和準確度。較新的型號能夠檢測較低濃度的一氧化氮，從而獲得更準確的讀數，並能夠更早診斷氣道發炎。這些改進對於確保 FeNO 檢測繼續作為氣喘和 COPD 管理的可靠工具至關重要，有助於做出更準確、更有效的治療決策。
  • 擴大 FeNO 檢測在臨床指引中的應用：FeNO 檢測正日益被納入全球氣喘管理的臨床指引。許多國家的醫療保健系統已經認知到 FeNO 檢測在氣喘診斷和管理中的重要性，並因此而廣泛採用這項技術。這項進展提高了醫療保健專業人員對 FeNO 檢測的接受度，並促進了其在常規臨床實踐中的應用。
  • 推出價格實惠的 FeNO檢測套組：為了提高可及性，一些製造商正在針對低收入群體和開發中國家推出價格實惠的 FeNO檢測套組。這些經濟高效的套件為那些無法負擔昂貴設備的地區大規模部署提供了可行的選擇。價格實惠的 FeNO 檢測方案的普及預計將推動新興市場的成長，這些市場中呼吸系統疾病盛行，但醫療基礎設施可能有限。

FeNO 檢測的最新趨勢，包括手持設備、與遠端醫療、準確性的提高、納入臨床指南以及價格實惠的套件，正在提高 FeNO 檢測的可及性、準確性和可整合性。這些技術創新正在促進市場的成長和擴張，使 FeNO 檢測成為氣喘和呼吸系統疾病管理的重要工具。

目錄

第1章摘要整理

第2章 市場概況

  • 背景和分類
  • 供應鏈

第3章：市場趨勢及預測分析

  • 宏觀經濟趨勢與預測
  • 產業驅動力與課題
  • PESTLE分析
  • 專利分析
  • 法規環境

4.全球FeNO 測試市場（依類型）

  • 概述
  • 依類型進行吸引力分析
  • 一氧化氮獨立監測儀：趨勢與預測（2019-2031）
  • 一氧化氮手持式監測儀：趨勢與預測（2019-2031）
  • 其他：趨勢與預測（2019-2031）

5.全球FeNO 測試市場（依應用）

  • 概述
  • 依用途進行吸引力分析
  • 醫院：趨勢與預測（2019-2031）
  • 診所：趨勢與預測（2019-2031）
  • 其他：趨勢與預測（2019-2031）

第6章 區域分析

  • 概述
  • 區域 FeNO 測試市場

7. 北美FeNO檢測市場

  • 概述
  • 美國FeNO測試市場
  • 墨西哥的FeNO檢測市場
  • 加拿大 FeNO 測試市場

8. 歐洲FeNO檢測市場

  • 概述
  • 德國FeNO測試市場
  • 法國FeNO檢測市場
  • 西班牙的FeNO測試市場
  • 義大利 FeNO 測試市場
  • 英國FeNO 測試市場

9. 亞太地區 FeNO 檢測市場

  • 概述
  • 日本的FeNO檢測市場
  • 印度FeNO測試市場
  • 中國FeNO檢測市場
  • 韓國FeNO檢測市場
  • 印尼FeNO測試市場

10. 世界其他地區 FeNO 檢測市場

  • 概述
  • 中東FeNO檢測市場
  • 南美洲 FeNO 檢測市場
  • 非洲 FeNO 檢測市場

第11章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析
    • 競爭對手之間的競爭
    • 買方的議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 新進入者的威脅
  • 市佔率分析

第12章：機會與策略分析

  • 價值鏈分析
  • 成長機會分析
    • 依類型分類的成長機會
    • 依應用分類的成長機會
  • 全球 FeNO 測試市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 認證和許可
    • 合併、收購、協議、合作和合資企業

第13章 價值鏈主要企業的公司簡介

  • 競爭分析
  • Guangzhou Kingmed Diagnostics
  • Hangzhou Clongene BIoTech
  • Shanghai Fosun Long March Medical Science
  • Nanjing Norman Biological Technology
  • Beijing Eastwest Harmony Medical Devices
  • Guangzhou Yercon Diagnostic
  • Aeonmed

第14章 附錄

  • 圖表目錄
  • 表格一覽
  • 調查方法
  • 免責聲明
  • 版權
  • 簡稱和技術單位
  • 關於我們
  • 聯絡處

The future of the global FeNO testing market looks promising with opportunities in the hospital and clinic markets. The global FeNO testing market is expected to grow with a CAGR of 14.1% from 2025 to 2031. The major drivers for this market are the rising prevalence of respiratory diseases, growing awareness of early diagnosis & personalized medicine, and the rising air pollution levels.

  • Lucintel forecasts that, within the type category, nitric oxide standalone monitor is expected to witness higher growth over the forecast period due to increasing prevalence of asthma and chronic respiratory diseases.
  • Within the application category, hospital is expected to witness the higher growth due to advanced healthcare infrastructure and high awareness for respiratory care programs.
  • In terms of region, North America is expected to witness the highest growth over the forecast period.

Emerging Trends in the FeNO Testing Market

The FeNO testing market is evolving rapidly, driven by advancements in technology, healthcare policies, and growing demand for non-invasive diagnostic methods. These emerging trends reflect broader changes in healthcare, including personalized medicine and the push for more effective chronic disease management. Below are five key trends shaping the future of the FeNO testing market.

  • Increasing Adoption of Home-Use Devices: Portable, user-friendly FeNO testing devices are being developed to allow patients to monitor their condition at home. This trend is transforming asthma management by providing patients with real-time data, enabling more personalized treatment plans. Home-use devices allow patients to track their condition outside of medical appointments, improving adherence to treatment and reducing hospital visits. As healthcare shifts towards more patient-centric models, these devices play a crucial role in empowering individuals to manage their respiratory health more effectively.
  • Integration with Digital Health Platforms: FeNO testing devices are increasingly being integrated with digital health platforms, enabling seamless data transfer to healthcare providers. This trend allows for better monitoring of asthma and other respiratory conditions, with real-time data helping doctors make more informed decisions. The integration of FeNO testing with electronic health records (EHRs) and telemedicine platforms is also improving patient care by enhancing communication between patients and healthcare professionals, ensuring timely adjustments to treatment plans and improving outcomes.
  • Advancements in Device Miniaturization and Portability: The market is seeing continuous innovation in making FeNO testing devices smaller, more portable, and easier to use. Miniaturization makes it possible for healthcare providers to use these devices in more settings, such as mobile clinics or remote areas. This trend is making FeNO testing more accessible in regions with limited healthcare infrastructure, where mobile or compact devices are easier to transport and deploy. Portable FeNO testing is particularly beneficial in rural areas and developing countries.
  • Growing Demand for Non-Invasive Diagnostic Tools: FeNO testing is part of a broader trend towards non-invasive diagnostics in healthcare. As patient preferences shift towards less invasive methods, FeNO testing is gaining popularity because it can measure airway inflammation without requiring blood draws or other invasive procedures. This trend is particularly relevant in the management of chronic diseases like asthma, where frequent monitoring is necessary. Non-invasive testing methods improve patient comfort and are expected to become a standard part of chronic disease management protocols.
  • Expansion of Reimbursement Policies: Reimbursement policies for FeNO testing are expanding in many countries, including the U.S. and European nations, as the clinical benefits of the test become more recognized. The inclusion of FeNO testing in insurance coverage helps reduce the cost barrier, making it more accessible to a broader population. In many regions, FeNO testing is being integrated into clinical guidelines for asthma management, ensuring that healthcare providers use it as part of a comprehensive treatment plan. This trend is contributing to the widespread adoption of FeNO testing.

Emerging trends such as home-use devices, digital integration, device miniaturization, demand for non-invasive diagnostics, and expanded reimbursement policies are significantly reshaping the FeNO testing market. These trends are driving growth by improving access to FeNO testing and enhancing its integration into routine healthcare practices, which will ultimately improve the management of respiratory diseases globally.

Recent Developments in the FeNO Testing Market

The FeNO testing market has seen numerous developments in recent years as the technology becomes more advanced and widely adopted. These developments reflect innovations in product design, increasing awareness of respiratory conditions, and advancements in healthcare infrastructure. The following are key recent developments that are shaping the FeNO testing market across various regions.

  • Introduction of Handheld FeNO Testers: One of the most significant developments in the FeNO testing market is the launch of handheld and portable FeNO testing devices. These devices allow for point-of-care testing, making it easier for healthcare providers to assess patients' airway inflammation quickly. Handheld testers are increasingly used in emergency rooms, clinics, and even at home for monitoring asthma. This development enhances the convenience and accessibility of FeNO testing, particularly in resource-limited settings.
  • Integration of FeNO Testing with Telemedicine: With the rise of telemedicine, FeNO testing devices are being integrated into telehealth platforms. This integration allows patients to take FeNO measurements at home and share the data with healthcare providers remotely. This trend is particularly beneficial for patients with chronic respiratory conditions, as it allows for continuous monitoring and timely adjustments to treatment plans. It also improves access to specialized care, particularly in rural or underserved areas.
  • Improvements in Device Sensitivity and Accuracy: Recent advancements have focused on improving the sensitivity and accuracy of FeNO testing devices. New models are able to detect lower concentrations of nitric oxide, providing more accurate readings and enabling earlier diagnosis of airway inflammation. These improvements are critical in ensuring that FeNO testing is a reliable tool for asthma and COPD management, leading to more precise and effective treatment decisions.
  • Expansion of FeNO Testing in Clinical Guidelines: FeNO testing is becoming increasingly integrated into clinical guidelines for asthma management worldwide. In many countries, national healthcare systems have recognized the importance of FeNO measurements in diagnosing and managing asthma, leading to more widespread use of the technology. This development is increasing the acceptance of FeNO testing among healthcare professionals and encouraging its adoption in routine clinical practice.
  • Launch of Affordable FeNO Testing Kits: To increase accessibility, some manufacturers have launched affordable FeNO testing kits aimed at low-income populations or developing countries. These cost-effective kits provide a viable option for large-scale deployment in areas where expensive equipment might be unaffordable. The availability of affordable FeNO testing options is expected to drive market growth in emerging markets, where respiratory conditions are prevalent but healthcare infrastructure may be limited.

Recent developments in FeNO testing, such as handheld devices, telemedicine integration, improved accuracy, clinical guideline inclusion, and affordable kits, are enhancing the accessibility, accuracy, and integration of FeNO testing. These innovations are contributing to the growth and expansion of the market, making FeNO testing an essential tool in the management of asthma and respiratory diseases.

Strategic Growth Opportunities in the FeNO Testing Market

As the FeNO testing market continues to expand, numerous growth opportunities exist across various applications. These opportunities are driven by the increasing prevalence of asthma and other respiratory conditions, technological advancements, and the growing demand for personalized healthcare. Below are five key strategic growth opportunities by application that can propel the FeNO testing market forward.

  • Growth in Point-of-Care Testing: Point-of-care testing is a significant growth opportunity for the FeNO testing market. The increasing demand for faster diagnostics in emergency rooms, clinics, and even in home settings is driving the adoption of portable FeNO testing devices. Point-of-care testing enables immediate assessment of airway inflammation, improving decision-making for asthma management and treatment. As healthcare systems move toward more accessible, patient-centered care, the demand for point-of-care FeNO testing solutions will continue to grow.
  • Expansion in Telemedicine Applications: Telemedicine offers a key growth opportunity for the FeNO testing market, particularly as more healthcare providers embrace remote patient monitoring. FeNO testing devices integrated into telehealth platforms allow for continuous asthma management, offering patients the convenience of monitoring their condition at home. This trend is especially valuable in rural areas or regions with limited access to healthcare specialists, making FeNO testing more accessible and effective in managing chronic respiratory conditions.
  • Increasing Use in Clinical Research: FeNO testing is increasingly being used in clinical research to study the effects of different asthma treatments and interventions. Researchers are adopting FeNO measurements to monitor inflammation and treatment response, making it a valuable tool for drug development and clinical trials. This growing use of FeNO testing in research provides opportunities for manufacturers to expand their market presence and target the pharmaceutical and clinical research sectors.
  • Focus on Emerging Markets: Emerging markets, particularly in regions such as Asia-Pacific and Latin America, present significant growth opportunities for the FeNO testing market. The rising prevalence of asthma and other respiratory diseases in these regions, coupled with improvements in healthcare infrastructure, is increasing demand for advanced diagnostic tools like FeNO testing. Expanding into these markets with cost-effective and portable solutions can drive market growth and improve access to high-quality asthma management in underserved regions.
  • Development of Personalized Medicine Applications: As personalized medicine becomes more prevalent, there is an increasing opportunity for FeNO testing to play a pivotal role in individualized treatment plans for asthma and COPD patients. By measuring airway inflammation in real-time, FeNO testing provides critical information that helps tailor treatments based on the patient's specific needs. The integration of FeNO testing into personalized medicine frameworks will drive its adoption and further establish its importance in chronic disease management.

Strategic growth opportunities in point-of-care testing, telemedicine, clinical research, emerging markets, and personalized medicine are driving the FeNO testing market forward. These opportunities are broadening the scope of FeNO testing and making it more accessible, efficient, and effective in managing asthma and respiratory diseases.

FeNO Testing Market Driver and Challenges

The FeNO testing market is influenced by a range of drivers and challenges, including technological advances, regulatory changes, and economic factors. These elements shape the growth trajectory and adoption of FeNO testing across different regions and applications. Below are five key drivers and three main challenges impacting the market, providing a comprehensive overview of the factors at play.

The factors responsible for driving the FeNO testing market include:

1. Increasing Prevalence of Respiratory Diseases: The rising global incidence of asthma and COPD is a major driver for the FeNO testing market. As the number of patients with these conditions increases, the demand for effective and non-invasive diagnostic tools like FeNO testing grows. FeNO testing helps in early detection and personalized treatment, making it an essential tool in managing respiratory diseases.

2. Technological Advancements in FeNO Testing Devices: Recent innovations in FeNO testing devices, including portable, handheld models and improved sensitivity, are driving market growth. These advancements make FeNO testing more accessible and accurate, allowing for wider adoption in both clinical and home settings. The continuous improvement of FeNO testing technology is enhancing the device's usability and increasing its clinical relevance.

3. Government Initiatives and Support for Respiratory Health: Governments around the world are investing in better healthcare infrastructure and promoting disease prevention programs, especially for chronic diseases like asthma. These initiatives support the adoption of FeNO testing as a valuable tool for early diagnosis and management. Policies that expand reimbursement for FeNO testing also boost market growth by making the technology more affordable and accessible.

4. Rising Demand for Personalized Healthcare: The shift towards personalized medicine, where treatments are tailored to individual patient needs, is driving demand for tools like FeNO testing. By measuring inflammation in the airways, FeNO testing helps healthcare providers personalize asthma management plans, ensuring better treatment outcomes. This growing trend toward individualized care is a strong driver for the market.

5. Expanding Healthcare Access in Emerging Markets: As healthcare access improves in emerging markets, the demand for advanced diagnostic tools like FeNO testing increases. The availability of portable and cost-effective FeNO testing devices is facilitating market growth in regions like Asia-Pacific, where the prevalence of asthma is on the rise. Expanding access to FeNO testing in these regions is a key driver for the market.

Challenges in the FeNO testing market are:

1. High Costs of FeNO Testing Devices: Despite the benefits of FeNO testing, the high cost of devices and related testing can be a barrier to adoption, particularly in low-income regions. While prices are decreasing with technological advancements, affordability remains a challenge for broader market penetration.

2. Regulatory Hurdles and Approval Delays: The approval process for medical devices, including FeNO testing equipment, can be lengthy and complex, with varying regulatory standards across regions. These hurdles may slow the introduction of new devices to the market and impact the speed of innovation, limiting the potential for rapid market growth.

3. Lack of Awareness and Training: In some regions, healthcare providers may lack awareness of FeNO testing or may not be trained in its use. This can lead to underutilization of the technology, particularly in emerging markets. Education and training programs are needed to ensure that healthcare providers can effectively integrate FeNO testing into their practice.

The FeNO testing market is being shaped by drivers such as the increasing prevalence of respiratory diseases, technological advancements, government support, demand for personalized healthcare, and expanded access in emerging markets. However, challenges like high device costs, regulatory delays, and a lack of awareness must be addressed to unlock the full potential of the market.

List of FeNO Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies FeNO testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the FeNO testing companies profiled in this report include-

  • Guangzhou Kingmed Diagnostics
  • Hangzhou Clongene Biotech
  • Shanghai Fosun Long March Medical Science
  • Nanjing Norman Biological Technology
  • Beijing Eastwest Harmony Medical Devices
  • Guangzhou Yercon Diagnostic
  • Aeonmed

FeNO Testing Market by Segment

The study includes a forecast for the global FeNO testing market by type, application, and region.

FeNO Testing Market by Type [Value from 2019 to 2031]:

  • Nitric Oxide Standalone Monitor
  • Nitric Oxide Handheld Monitor
  • Others

FeNO Testing Market by Application [Value from 2019 to 2031]:

  • Hospital
  • Clinic
  • Others

FeNO Testing Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the FeNO Testing Market

The FeNO (Fractional exhaled Nitric Oxide) testing market has experienced significant growth due to its role in the diagnosis and management of respiratory conditions like asthma. This non-invasive method helps measure airway inflammation, offering a critical tool for clinicians in assessing asthma severity and treatment effectiveness. As healthcare systems evolve and patient care becomes more personalized, the adoption of FeNO testing is increasing globally. Below, we highlight recent developments in FeNO testing across key markets such as the United States, China, Germany, India, and Japan, showcasing innovations, regulatory changes, and growing adoption.

  • United States: In the U.S., FeNO testing is gaining popularity as a standard tool for managing asthma and chronic obstructive pulmonary disease (COPD). The increased focus on precision medicine and personalized healthcare has fueled the demand for more accurate and non-invasive diagnostic tools. Recent advancements in FeNO testing devices, such as portable and handheld devices, have improved accessibility and patient compliance. Additionally, healthcare providers are increasingly incorporating FeNO measurements alongside traditional tests for better asthma control. Medicare and private insurers have expanded reimbursement policies for FeNO testing, facilitating its wider adoption in clinical practices across the country.
  • China: China has seen a rising adoption of FeNO testing due to the country's growing healthcare demands, particularly in urban areas. With an increasing prevalence of asthma and other respiratory diseases, Chinese healthcare providers are turning to FeNO testing as an effective diagnostic tool. The market is also benefiting from government efforts to enhance healthcare infrastructure and improve chronic disease management. Local manufacturers are developing cost-effective FeNO testing devices tailored to meet the needs of a broader population, which is helping to make the technology more accessible. Awareness campaigns and improvements in the overall healthcare system are driving market growth.
  • Germany: Germany's healthcare system is well-established, and the country has seen steady adoption of FeNO testing within clinical and research settings. In line with broader European healthcare trends, Germany has been focusing on improving early diagnosis and personalized treatment plans for asthma and other respiratory conditions. The country's regulatory environment supports the use of FeNO testing, with strong integration into clinical guidelines for asthma management. Moreover, German medical device manufacturers are advancing FeNO testing technologies, incorporating features such as wireless connectivity for data sharing and integration with electronic health records, enhancing overall patient care.
  • India: In India, FeNO testing is still emerging but gaining momentum, particularly in larger cities with better healthcare infrastructure. The increasing awareness of asthma, along with the rising prevalence of air pollution-related respiratory conditions, has highlighted the need for advanced diagnostic tools. However, the adoption of FeNO testing is hampered by cost-related concerns, though the growing availability of affordable, portable devices is expected to increase adoption. Local healthcare initiatives are also working to improve access to non-invasive diagnostic tools for asthma and COPD, which could drive further growth in the FeNO testing market in the coming years.
  • Japan: Japan has been a leader in adopting advanced diagnostic tools, and FeNO testing is becoming more integrated into the management of respiratory conditions, especially in asthma. The country is focusing on advancing precision medicine and improving the monitoring of chronic diseases through non-invasive technologies. FeNO testing is included in national guidelines for asthma management, increasing its usage among healthcare professionals. The Japanese market is seeing innovations in FeNO measurement devices, including improved sensitivity and the development of home-use testing kits, offering more convenient and patient-friendly options for asthma monitoring and management.

Features of the Global FeNO Testing Market

  • Market Size Estimates: FeNO testing market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: FeNO testing market size by type, application, and region in terms of value ($B).
  • Regional Analysis: FeNO testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the FeNO testing market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the FeNO testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the FeNO testing market by type (nitric oxide standalone monitor, nitric oxide handheld monitor, and others), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global FeNO Testing Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Nitric Oxide Standalone Monitor: Trends and Forecast (2019-2031)
  • 4.4 Nitric Oxide Handheld Monitor: Trends and Forecast (2019-2031)
  • 4.5 Others: Trends and Forecast (2019-2031)

5. Global FeNO Testing Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Hospital: Trends and Forecast (2019-2031)
  • 5.4 Clinic: Trends and Forecast (2019-2031)
  • 5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global FeNO Testing Market by Region

7. North American FeNO Testing Market

  • 7.1 Overview
  • 7.4 United States FeNO Testing Market
  • 7.5 Mexican FeNO Testing Market
  • 7.6 Canadian FeNO Testing Market

8. European FeNO Testing Market

  • 8.1 Overview
  • 8.4 German FeNO Testing Market
  • 8.5 French FeNO Testing Market
  • 8.6 Spanish FeNO Testing Market
  • 8.7 Italian FeNO Testing Market
  • 8.8 United Kingdom FeNO Testing Market

9. APAC FeNO Testing Market

  • 9.1 Overview
  • 9.4 Japanese FeNO Testing Market
  • 9.5 Indian FeNO Testing Market
  • 9.6 Chinese FeNO Testing Market
  • 9.7 South Korean FeNO Testing Market
  • 9.8 Indonesian FeNO Testing Market

10. ROW FeNO Testing Market

  • 10.1 Overview
  • 10.4 Middle Eastern FeNO Testing Market
  • 10.5 South American FeNO Testing Market
  • 10.6 African FeNO Testing Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global FeNO Testing Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 Guangzhou Kingmed Diagnostics
    • Company Overview
    • FeNO Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Hangzhou Clongene Biotech
    • Company Overview
    • FeNO Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Shanghai Fosun Long March Medical Science
    • Company Overview
    • FeNO Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Nanjing Norman Biological Technology
    • Company Overview
    • FeNO Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Beijing Eastwest Harmony Medical Devices
    • Company Overview
    • FeNO Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 Guangzhou Yercon Diagnostic
    • Company Overview
    • FeNO Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Aeonmed
    • Company Overview
    • FeNO Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global FeNO Testing Market
  • Figure 2.1: Usage of FeNO Testing Market
  • Figure 2.2: Classification of the Global FeNO Testing Market
  • Figure 2.3: Supply Chain of the Global FeNO Testing Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 3.19: Driver and Challenges of the FeNO Testing Market
  • Figure 4.1: Global FeNO Testing Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global FeNO Testing Market ($B) by Type
  • Figure 4.3: Forecast for the Global FeNO Testing Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Nitric Oxide Standalone Monitor in the Global FeNO Testing Market (2019-2031)
  • Figure 4.5: Trends and Forecast for Nitric Oxide Handheld Monitor in the Global FeNO Testing Market (2019-2031)
  • Figure 4.6: Trends and Forecast for Others in the Global FeNO Testing Market (2019-2031)
  • Figure 5.1: Global FeNO Testing Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global FeNO Testing Market ($B) by Application
  • Figure 5.3: Forecast for the Global FeNO Testing Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Hospital in the Global FeNO Testing Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Clinic in the Global FeNO Testing Market (2019-2031)
  • Figure 5.6: Trends and Forecast for Others in the Global FeNO Testing Market (2019-2031)
  • Figure 6.1: Trends of the Global FeNO Testing Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global FeNO Testing Market ($B) by Region (2025-2031)
  • Figure 7.1: Trends and Forecast for the North American FeNO Testing Market (2019-2031)
  • Figure 7.2: North American FeNO Testing Market by Type in 2019, 2024, and 2031
  • Figure 7.3: Trends of the North American FeNO Testing Market ($B) by Type (2019-2024)
  • Figure 7.4: Forecast for the North American FeNO Testing Market ($B) by Type (2025-2031)
  • Figure 7.5: North American FeNO Testing Market by Application in 2019, 2024, and 2031
  • Figure 7.6: Trends of the North American FeNO Testing Market ($B) by Application (2019-2024)
  • Figure 7.7: Forecast for the North American FeNO Testing Market ($B) by Application (2025-2031)
  • Figure 7.8: Trends and Forecast for the United States FeNO Testing Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Mexican FeNO Testing Market ($B) (2019-2031)
  • Figure 7.10: Trends and Forecast for the Canadian FeNO Testing Market ($B) (2019-2031)
  • Figure 8.1: Trends and Forecast for the European FeNO Testing Market (2019-2031)
  • Figure 8.2: European FeNO Testing Market by Type in 2019, 2024, and 2031
  • Figure 8.3: Trends of the European FeNO Testing Market ($B) by Type (2019-2024)
  • Figure 8.4: Forecast for the European FeNO Testing Market ($B) by Type (2025-2031)
  • Figure 8.5: European FeNO Testing Market by Application in 2019, 2024, and 2031
  • Figure 8.6: Trends of the European FeNO Testing Market ($B) by Application (2019-2024)
  • Figure 8.7: Forecast for the European FeNO Testing Market ($B) by Application (2025-2031)
  • Figure 8.8: Trends and Forecast for the German FeNO Testing Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the French FeNO Testing Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Spanish FeNO Testing Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the Italian FeNO Testing Market ($B) (2019-2031)
  • Figure 8.12: Trends and Forecast for the United Kingdom FeNO Testing Market ($B) (2019-2031)
  • Figure 9.1: Trends and Forecast for the APAC FeNO Testing Market (2019-2031)
  • Figure 9.2: APAC FeNO Testing Market by Type in 2019, 2024, and 2031
  • Figure 9.3: Trends of the APAC FeNO Testing Market ($B) by Type (2019-2024)
  • Figure 9.4: Forecast for the APAC FeNO Testing Market ($B) by Type (2025-2031)
  • Figure 9.5: APAC FeNO Testing Market by Application in 2019, 2024, and 2031
  • Figure 9.6: Trends of the APAC FeNO Testing Market ($B) by Application (2019-2024)
  • Figure 9.7: Forecast for the APAC FeNO Testing Market ($B) by Application (2025-2031)
  • Figure 9.8: Trends and Forecast for the Japanese FeNO Testing Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Indian FeNO Testing Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the Chinese FeNO Testing Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the South Korean FeNO Testing Market ($B) (2019-2031)
  • Figure 9.12: Trends and Forecast for the Indonesian FeNO Testing Market ($B) (2019-2031)
  • Figure 10.1: Trends and Forecast for the ROW FeNO Testing Market (2019-2031)
  • Figure 10.2: ROW FeNO Testing Market by Type in 2019, 2024, and 2031
  • Figure 10.3: Trends of the ROW FeNO Testing Market ($B) by Type (2019-2024)
  • Figure 10.4: Forecast for the ROW FeNO Testing Market ($B) by Type (2025-2031)
  • Figure 10.5: ROW FeNO Testing Market by Application in 2019, 2024, and 2031
  • Figure 10.6: Trends of the ROW FeNO Testing Market ($B) by Application (2019-2024)
  • Figure 10.7: Forecast for the ROW FeNO Testing Market ($B) by Application (2025-2031)
  • Figure 10.8: Trends and Forecast for the Middle Eastern FeNO Testing Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the South American FeNO Testing Market ($B) (2019-2031)
  • Figure 10.10: Trends and Forecast for the African FeNO Testing Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global FeNO Testing Market
  • Figure 11.2: Market Share (%) of Top Players in the Global FeNO Testing Market (2024)
  • Figure 12.1: Growth Opportunities for the Global FeNO Testing Market by Type
  • Figure 12.2: Growth Opportunities for the Global FeNO Testing Market by Application
  • Figure 12.3: Growth Opportunities for the Global FeNO Testing Market by Region
  • Figure 12.4: Emerging Trends in the Global FeNO Testing Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the FeNO Testing Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the FeNO Testing Market by Region
  • Table 1.3: Global FeNO Testing Market Parameters and Attributes
  • Table 3.1: Trends of the Global FeNO Testing Market (2019-2024)
  • Table 3.2: Forecast for the Global FeNO Testing Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global FeNO Testing Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global FeNO Testing Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global FeNO Testing Market (2025-2031)
  • Table 4.4: Trends of Nitric Oxide Standalone Monitor in the Global FeNO Testing Market (2019-2024)
  • Table 4.5: Forecast for Nitric Oxide Standalone Monitor in the Global FeNO Testing Market (2025-2031)
  • Table 4.6: Trends of Nitric Oxide Handheld Monitor in the Global FeNO Testing Market (2019-2024)
  • Table 4.7: Forecast for Nitric Oxide Handheld Monitor in the Global FeNO Testing Market (2025-2031)
  • Table 4.8: Trends of Others in the Global FeNO Testing Market (2019-2024)
  • Table 4.9: Forecast for Others in the Global FeNO Testing Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global FeNO Testing Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global FeNO Testing Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global FeNO Testing Market (2025-2031)
  • Table 5.4: Trends of Hospital in the Global FeNO Testing Market (2019-2024)
  • Table 5.5: Forecast for Hospital in the Global FeNO Testing Market (2025-2031)
  • Table 5.6: Trends of Clinic in the Global FeNO Testing Market (2019-2024)
  • Table 5.7: Forecast for Clinic in the Global FeNO Testing Market (2025-2031)
  • Table 5.8: Trends of Others in the Global FeNO Testing Market (2019-2024)
  • Table 5.9: Forecast for Others in the Global FeNO Testing Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global FeNO Testing Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global FeNO Testing Market (2025-2031)
  • Table 7.1: Trends of the North American FeNO Testing Market (2019-2024)
  • Table 7.2: Forecast for the North American FeNO Testing Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various Type in the North American FeNO Testing Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various Type in the North American FeNO Testing Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various Application in the North American FeNO Testing Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various Application in the North American FeNO Testing Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States FeNO Testing Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican FeNO Testing Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian FeNO Testing Market (2019-2031)
  • Table 8.1: Trends of the European FeNO Testing Market (2019-2024)
  • Table 8.2: Forecast for the European FeNO Testing Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various Type in the European FeNO Testing Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various Type in the European FeNO Testing Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various Application in the European FeNO Testing Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various Application in the European FeNO Testing Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German FeNO Testing Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French FeNO Testing Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish FeNO Testing Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian FeNO Testing Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom FeNO Testing Market (2019-2031)
  • Table 9.1: Trends of the APAC FeNO Testing Market (2019-2024)
  • Table 9.2: Forecast for the APAC FeNO Testing Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC FeNO Testing Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC FeNO Testing Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC FeNO Testing Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC FeNO Testing Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese FeNO Testing Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian FeNO Testing Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese FeNO Testing Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean FeNO Testing Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian FeNO Testing Market (2019-2031)
  • Table 10.1: Trends of the ROW FeNO Testing Market (2019-2024)
  • Table 10.2: Forecast for the ROW FeNO Testing Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW FeNO Testing Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW FeNO Testing Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW FeNO Testing Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW FeNO Testing Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern FeNO Testing Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American FeNO Testing Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African FeNO Testing Market (2019-2031)
  • Table 11.1: Product Mapping of FeNO Testing Suppliers Based on Segments
  • Table 11.2: Operational Integration of FeNO Testing Manufacturers
  • Table 11.3: Rankings of Suppliers Based on FeNO Testing Revenue
  • Table 12.1: New Product Launches by Major FeNO Testing Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global FeNO Testing Market